Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024). Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduction and Targeted Therapy, 9, 175.
PubMed PubMed Central Google Scholar
Juthani, R., Punatar, S., & Mittra, I. (2024). New light on chemotherapy toxicity and its prevention. BJC Reports, 2, 41.
PubMed PubMed Central Google Scholar
Dasari, S., & Bernard Tchounwou, P. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378.
CAS PubMed PubMed Central Google Scholar
Ghosh, S. (2019). Cisplatin: The first metal based anticancer drug. Bioorganic Chemistry, 88, Article 102925.
Davodabadi, F., Sajjadi, S. F., Sarhadi, M., Mirghasemi, S., Nadali Hezaveh, M., Khosravi, S., Kamali Andani, M., Cordani, M., Basiri, M., & Ghavami, S. (2023). Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery. European Journal of Pharmacology, 958, Article 176013.
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmaceutical Bulletin, 7, 339–348.
CAS PubMed PubMed Central Google Scholar
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003). Photodynamic therapy for cancer. Nature Reviews Cancer, 3, 380–387.
Chilakamarthi, U., & Giribabu, L. (2017). Photodynamic therapy: Past, present and future. The Chemical Record, 17, 775–802.
Agostinis, P., Berg, K., Cengel, K. A., et al. (2011). Photodynamic therapy of cancer: An update. CA: A Cancer Journal for Clinicians, 61, 250–281.
Henderson, B. W., & Dougherty, T. J. (1992). How does photodynamic therapy work? Photochemistry and Photobiology, 55, 145–157.
Feng, Y., Coradi Tonon, C., Ashraf, S., & Hasan, T. (2021). Photodynamic and antibiotic therapy in combination against bacterial infections: Efficacy, determinants, mechanisms, and future perspectives. Advanced Drug Delivery Reviews, 177, Article 113941.
Li, M., Tao, Y., Tang, J., Wang, Y., Zhang, X., Tao, Y., & Wang, X. (2019). Synergetic organocatalysis for eliminating epimerization in ring-opening polymerizations enables synthesis of stereoregular isotactic polyester. Journal of the American Chemical Society, 141, 281–289.
Kawczyk-Krupka, A., Pucelik, B., Międzybrodzka, A., Sieroń, A., & Dąbrowski, J. M. (2018). Photodynamic therapy as an alternative to antibiotic therapy for the treatment of infected leg ulcers. Photodiagnosis and Photodynamic Therapy. https://doi.org/10.1016/j.pdpdt.2018.05.001
Galinari, C. B., Biachi, T. D. P., Gonçalves, R. S., Cesar, G. B., Bergmann, E. V., Malacarne, L. C., Kioshima Cotica, É. S., Bonfim-Mendonça, P. D. S., & Svidzinski, T. I. E. (2023). Photoactivity of hypericin: From natural product to antifungal application. Critical Reviews in Microbiology, 49, 38–56.
Lin, S., Liu, C., Han, X., Zhong, H., & Cheng, C. (2021). Viral nanoparticle system: An effective platform for photodynamic therapy. IJMS, 22, 1728.
CAS PubMed PubMed Central Google Scholar
Benov, L. (2015). Photodynamic therapy: Current status and future directions. Medical Principles and Practice, 24, 14–28.
Pham, T. C., Nguyen, V. N., Choi, Y., Lee, S., & Yoon, J. (2021). Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy. Chemical Reviews, 121, 13454–13619.
Garland, M. J., Cassidy, C. M., Woolfson, D., & Donnelly, R. F. (2009). Designing photosensitizers for photodynamic therapy: Strategies, challenges and promising developments. Future Medicinal Chemistry, 1, 667–691.
Correia, J. H., Rodrigues, J. A., Pimenta, S., Dong, T., & Yang, Z. (2021). Photodynamic therapy review: Principles, photosensitizers, applications, and future directions. Pharmaceutics, 13, 1332.
CAS PubMed PubMed Central Google Scholar
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023). Hypoxic microenvironment in cancer: Molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy, 8, 70.
PubMed PubMed Central Google Scholar
Bonnet, S. (2018). Why develop photoactivated chemotherapy? Dalton Transactions, 47, 10330–10343.
Zhou, X.-Q., Wang, P., Ramu, V., et al. (2023). In vivo metallophilic self-assembly of a light-activated anticancer drug. Nature Chemistry, 15, 980–987.
CAS PubMed PubMed Central Google Scholar
Askes, S. H. C., Bahreman, A., & Bonnet, S. (2014). Activation of a photodissociative ruthenium complex by triplet-triplet annihilation upconversion in liposomes. Angewandte Chemie, 126, 1047–1051.
Delova, A., Losantos, R. R., Pecourneau, J., Bernhard, Y., Mourere, M., Pasc, A., & Monari, A. (2022). Phase transitions in lipid bilayers by biomimetic photoswitches based on cyclocurcumin. BioRxiv. https://doi.org/10.1101/2022.09.11.507454
Losantos, R., Pecourneau, J., Mourer, M., Parant, S., Pasc, A., & Monari, A. (2021). trans-cis Photoisomerization of a biomimetic cyclocurcumin analogue rationalized by molecular modelling. Physical Chemistry Chemical Physics: PCCP, 23, 12842–12849.
Pecourneau, J., Losantos, R., Monari, A., Parant, S., Pasc, A., & Mourer, M. (2021). Synthesis and photoswitching properties of bioinspired dissymmetric γ-pyrone, an analogue of cyclocurcumin. Journal of Organic Chemistry, 86, 8112–8126.
García-López, V., Chen, F., Nilewski, L. G., Duret, G., Aliyan, A., Kolomeisky, A. B., Robinson, J. T., Wang, G., Pal, R., & Tour, J. M. (2017). Molecular machines open cell membranes. Nature, 548, 567–572.
Aslanoglu, B., Yakavets, I., Zorin, V., Lassalle, H. P., Ingrosso, F., Monari, A., & Catak, S. (2020). Optical properties of photodynamic therapy drugs in different environments: The paradigmatic case of temoporfin. Physical Chemistry Chemical Physics, 22, 16956–16964.
Koca Fındık, B., Yakavets, I., Lassalle, H.-P., Catak, S., & Monari, A. (2024). Efficient delivering of a photodynamic therapy drug into cellular membranes rationalized by molecular dynamics. The Journal of Physical Chemistry B, 128, 11625–11633.
Koca, B., Hamuryudan, E., Catak, S., Erdogmus, A., Monari, A., & Aviyente, V. (2019). Exploring the photophysics of polyfluorinated phthalocyanine derivatives as potential theranostic agents. Journal of Physical Chemistry C, 123, 24417–24425.
Chatterjee, D. K., Fong, L. S., & Zhang, Y. (2008). Nanoparticles in photodynamic therapy: An emerging paradigm. Advanced Drug Delivery Reviews, 60, 1627–1637.
Abrahamse, H., & Hamblin, M. R. (2016). New photosensitizers for photodynamic therapy. Biochemical Journal, 473, 347–364.
Merlin, J. P. J., Crous, A., & Abrahamse, H. (2024). Combining photodynamic therapy and targeted drug delivery systems: Enhancing mitochondrial toxicity for improved cancer outcomes. IJMS, 25, 10796.
CAS PubMed PubMed Central Google Scholar
Moret, F., & Varchi, G. (2023). Drug delivery in photodynamic therapy. Pharmaceutics, 15, 1784.
PubMed PubMed Central Google Scholar
Dilliard, S. A., & Siegwart, D. J. (2023). Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nature Reviews Materials, 8, 282–300.
CAS PubMed PubMed Central Google Scholar
Jones, H. J., Vernon, D. I., & Brown, S. B. (2003). Photodynamic therapy effect of m-THPC (Foscan®) in vivo: Correlation with pharmacokinetics. British Journal of Cancer, 89, 398–404.
CAS PubMed PubMed Central Google Scholar
Upponi, J. R., & Torchilin, V. P. (2014). Passive vs. active targeting: An update of the EPR role in drug delivery to tumors. In M. J. Alonso & M. Garcia-Fuentes (Eds.), Nano-oncologicals: New targeting and delivery approaches (pp. 3–45). Springer International Publishing.
Yakavets, I., Lassalle, H. P., Yankovsky, I., Ingrosso, F., Monari, A., Bezdetnaya, L., & Zorin, V. (2018). Evaluation of temoporfin affinity to β-cyclodextrins assuming self-aggregation. Journal of Photochemistry and Photobiology A: Chemistry, 367, 13–21.
Comments (0)